Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1978 Sep 23;2(6141):893.

Postoperative morbidity and mortality after bleomycin treatment

Paul L Goldiner, Graziano C Carlon
PMCID: PMC1607972

Full text

PDF

Page 893

893

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Holoye P. Y., Luna M. A., MacKay B., Bedrossian C. W. Bleomycin hypersensitivity pneumonitis. Ann Intern Med. 1978 Jan;88(1):47–49. doi: 10.7326/0003-4819-88-1-47. [DOI] [PubMed] [Google Scholar]
  2. Nygaard K., Smith-Erichsen N., Hatlevoll R., Refsum S. B. Pulmonary complications after bleomycin, irradiation and surgery for esophageal cancer. Cancer. 1978 Jan;41(1):17–22. doi: 10.1002/1097-0142(197801)41:1<17::aid-cncr2820410105>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  3. Samuels M. L., Holoye P. Y., Johnson D. E. Bleomycin combination chemotherapy in the management of testicular neoplasia. Cancer. 1975 Aug;36(2):318–326. doi: 10.1002/1097-0142(197508)36:2<318::aid-cncr2820360205>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  4. Samuels M. L., Johnson D. E., Holoye P. Y. Continuous intravenous bleomycin (NSC-125066) therapy with vinblastine (NSC-49842) in stage III testicular neoplasia. Cancer Chemother Rep. 1975 May-Jun;59(3):563–570. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES